Skip to content

Hybrid closed loop insulin pump system for people with diabetes caused by chronic pancreatitis

Advanced hybrid Closed Loop In people with diabetes secondary to chronic Pancreatitis (CLIP): A feasibility randomised controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN24340577
Enrollment
24
Registered
2026-05-06
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, chronic pancreatitis Nutritional, Metabolic, Endocrine

Interventions

If participants are interested to take part, they will be invited to an initial baseline visit to complete baseline assessments and have blood samples taken. These samples will include routine blood s

Sponsors

Newcastle upon Tyne Hospitals NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 120 Years

Inclusion criteria

Inclusion criteria: 1. A confirmed diagnosis of CP and diabetes 2. Age >=18 years 3. HbA1c >=58mmol/mol or disabling hypoglycaemia (when hypoglycaemia occurs frequently or without warning, so the person is constantly anxious about having hypoglycaemic episodes) at screening as per NICE guidance 4. On insulin (twice daily or MDI) 5. Minimal daily insulin requirement of >=8 units and maximum of 250 units per day

Exclusion criteria

Exclusion criteria: 1. Known diagnosis of T1DM or T2M 2. Age =18 years 3. History of pancreatic cancer 4. Pregnant or planning pregnancy or breastfeeding 5. History of partial or total pancreatectomy, excluding Frey’s procedure 6. Currently using an insulin pump 7. Hearing or visual impairment or impairment in dexterity that would hinder ability to manage study devices 8. Untreated coeliac disease, adrenal insufficiency or hyperthyroidism or hypothyroidism 9. Current alcohol excess or illicit drug misuse or prescription drug abuse 10. Diagnosed with an eating disorder 11. Skin conditions located at sites of sensor insertion such as psoriasis or bacterial skin infection 12. Any condition that in the assessment of the investigator would impair the ability of the participant to give informed consent

Countries

England, United Kingdom

Contacts

Public ContactAyat Bashir
ayat.bashir@ncl.ac.uk-

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jun 21, 2026